問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2012-06-01 - 2018-05-31
Condition/Disease
Test Drug
Participate Sites6Sites
Terminated6Sites
2013-12-01 - 2018-12-31
Participate Sites5Sites
Terminated5Sites
2013-12-01 - 2022-12-31
Chronic Hepatitis B
1.Tenofovir Alafenamide (TAF, GS-7340)、 2.Tenofovir Disoproxil Fumarate (TDF, Viread®)
Participate Sites8Sites
Terminated8Sites
2013-11-01 - 2021-12-31
C. difficile Infection
C. difficile Toxoid Vaccine
Participate Sites7Sites
Terminated7Sites
2011-05-01 - 2014-12-31
Participate Sites4Sites
Terminated4Sites
2011-09-01 - 2013-12-31
2019-01-01 - 2020-02-05
Participate Sites3Sites
Terminated3Sites
2022-01-01 - 2025-12-31
Participate Sites2Sites
Recruiting2Sites
2014-02-01 - 2016-01-30
2014-01-01 - 2016-12-31
全部
